Advanced intercross line mapping of Eae5 reveals Ncf-1 and CLDN4 as candidate genes for experimental autoimmune encephalomyelitis

Journal of Immunology

Volumn 176, Issue 10, 2006, Pages 6055-6064

  Becanovic, Kristina ^a,d   Jagodic, Maja ^a   Sheng, Jian Rong ^a   Dahlman, Ingrid ^a   Aboul Enein, Fahmy ^b   Wallstrom, Erik ^a   Olofsson, Peter ^c   Holmdahl, Rikard ^c   Lassmann, Hans ^b   Olsson, Tomas ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF VIENNA   (Austria)

^c LUND UNIVERSITY   (Sweden)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

MYELIN OLIGODENDROCYTE GLYCOPROTEIN;

ALLELE; ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; BLOOD BRAIN BARRIER; CHROMOSOME 12; CLDN4 GENE; CONTROLLED STUDY; DEMYELINATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; EAE5 GENE; GENE; GENE IDENTIFICATION; GENE LOCUS; GENE MAPPING; GENETIC ASSOCIATION; GENETIC LINKAGE; NCF 1 GENE; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PIA4 GENE; PRIORITY JOURNAL; RAT; REGULATOR GENE;

EID: 33646493351     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.176.10.6055     Document Type: Article

References (55)

1. Sadovnick, A. D., P. A. Baird, and R. H. Ward. 1988. Multiple sclerosis: updated risks for relatives. Am. J. Med. Genet. 29: 533-541.
2. Svejgaard, A., C. Jersild, L. S. Nielsen, and W. F. Bodmer. 1974. HL-A antigens and disease: statistical and genetical considerations. Tissue Antigens 4: 95-105.
3. Jersild, C., B. Dupont, A. Svejgaard, P. J. Platz, K. A. Ciongoli, and T. Fog. 1975. Proceedings: Genetic factors in multiple sclerosis: the major histocompatibility system (HL-A) and immunity. Neurology 25: 488-489.
4. Masterman, T., A. Ligers, T. Olsson, M. Andersson, O. Olerup, and J. Hillert. 2000. HLA-DR15 is associated with lower age at onset in multiple sclerosis. Ann. Neurol. 48: 211-219.
5. Olerup, O., and J. Hillert. 1991. HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation. Tissue Antigens 38: 1-15.
6. Sundvall, M., J. Jirholt, H. T. Yang, L. Jansson, A. Engstrom, U. Pettersson, and R. Holmdahl. 1995. Identification of murine loci associated with susceptibility to chronic experimental autoimmune encephalomyelitis. Nat. Genet. 10: 313-317.
7. Baker, D., O. A. Rosenwasser, J. K. O'Neill, and J. L. Turk. 1995. Genetic analysis of experimental allergic encephalomyelitis in mice. J. Immunol. 155: 4046-4051.
8. Butterfield, R. J., J. D. Sudweeks, E. P. Blankenhorn, R. Korngold, J. C. Marini, J. A. Todd, R. J. Roper, and C. Teuscher. 1998. New genetic loci that control susceptibility and symptoms of experimental allergic encephalomyelitis in inbred mice. J. Immunol. 161: 1860-1867.
9. Dahlman, I., L. Jacobsson, A. Glaser, J. C. Lorentzen, M. Andersson, H. Luthman, and T. Olsson. 1999. Genome-wide linkage analysis of chronic relapsing experimental autoimmune encephalomyelitis in the rat identifies a major susceptibility locus on chromosome 9. J. Immunol. 162: 2581-2588.
10. Dahlman, I., E. Wallstrom, R. Weissert, M. Storch, B. Kornek, L. Jacobsson, C. Linington, H. Luthman, H. Lassmann, and T. Olsson. 1999. Linkage analysis of myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in the rat identifies a locus controlling demyelination on chromosome 18. Hum. Mol. Genet. 8: 2183-2190.
11. Roth, M. P., C. Viratelle, L. Dolbois, M. Delverdier, N. Borot, L. Pelletier, P. Druet, M. Clanet, and H. Coppin. 1999. A genome-wide search identifies two susceptibility loci for experimental autoimmune encephalomyelitis on rat chromosomes 4 and 10. J. Immunol. 162: 1917-1922.
12. Encinas, J. A., and V. K. Kuchroo. 2000. Mapping and identification of autoimmunity genes. Curr. Opin. Immunol 12: 691-697.
13. Encinas, J. A., M. B. Lees, R. A. Sobel, C. Symonowicz, H. L. Weiner, C. E. Seidman, J. G. Seidman, and V. K. Kuchroo. 2001. Identification of genetic loci associated with paralysis, inflammation and weight loss in mouse experimental autoimmune encephalomyelitis. Int. Immunol. 13: 257-264.
14. Bergsteinsdottir, K., H. T. Yang, U. Pettersson, and R. Holmdahl. 2000. Evidence for common autoimmune disease genes controlling onset, severity, and chronicity based on experimental models for multiple sclerosis and rheumatoid arthritis. J. Immunol. 164: 1564-1568.
15. Becanovic, K., E. Wallstrom, B. Kornek, A. Glaser, K. W. Broman, I. Dahlman, P. Olofsson, R. Holmdahl, H. Luthman, H. Lassmann, and T. Olsson. 2003. New loci regulating rat myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis. J. Immunol. 170: 1062-1069.
16. Darvasi, A., and M. Soller. 1995. Advanced intercross lines, an experimental population for fine genetic mapping. Genetics 141: 1199-1207.
17. Vingsbo-Lundberg, C., N. Nordquist, P. Olofsson, M. Sundvall, T. Saxne, U. Pettersson, and R. Holmdahl. 1998. Genetic control of arthritis onset, severity and chronicity in a model for rheumatoid arthritis in rats. Nat. Genet. 20: 401-404.
18. Olofsson, P., J. Holmberg, J. Tordsson, S. Lu, B. Akerstrom, and R. Holmdahl. 2003. Positional identification of Ncf1 as a gene that regulates arthritis severity in rats. Nat. Genet. 33: 25-32.
19. Weissert, R., E. Wallstrom, M. K. Storch, A. Stefferl, J. Lorentzen, H. Lassmann, C. Linington, and T. Olsson. 1998. MHC haplotype-dependent regulation of MOG-induced EAE in rats. J. Clin. Invest. 102: 1265-1273.
20. Storch, M. K., A. Stefferl, U. Brehm, R. Weissert, E. Wallstrom, M. Kerschensteiner, T. Olsson, C. Linington, and H. Lassmann. 1998. Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology. Brain Pathol. 8: 681-694.
21. Kornek, B., M. K. Storch, R. Weissert, E. Wallstrom, A. Stefferl, T. Olsson, C. Linington, M. Schmidbauer, and H. Lassmann. 2000. Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions. Am. J. Pathol. 157: 267-276.
22. Lyons, J. A., M. San, M. P. Happ, and A. H. Cross. 1999. B cells are critical to induction of experimental allergic encephalomyelitis by protein but not by a short encephalitogenic peptide. Eur. J. Immunol. 29: 3432-3439.
23. Lyons, J. A., M. J. Ramsbottom, and A. H. Cross. 2002. Critical role of antigen-specific antibody in experimental autoimmune encephalomyelitis induced by recombinant myelin oligodendrocyte glycoprotein. Eur. J. Immunol. 32: 1905-1913.
24. Linington, C., M. Bradl, H. Lassmann, C. Brunner, and K. Vass. 1988. Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/ oligodendrocyte glycoprotein. Am. J. Pathol. 130: 443-454.
25. Weissert, R., K. L. de Graaf, M. K. Storch, S. Barth, C. Linington, H. Lassmann, and T. Olsson. 2001. MHC class II-regulated central nervous system autoaggression and T cell responses in peripheral lymphoid tissues are dissociated in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis. J. Immunol. 166: 7588-7599.
26. Haines, J. L., M. Ter-Minassian, A. Bazyk, J. F. Gusella, D. J. Kim, H. Terwedow, M. A. Pericak-Vance, J. B. Rimmler, C. S. Haynes, A. D. Roses, et al. 1996. A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complex. Nat. Genet. 13: 469-471.
27. Wolburg, H., K. Wolburg-Buchholz, J. Kraus, G. Rascher-Eggstein, S. Liebner, S. Hamm, F. Duffner, E. H. Grote, W. Risau, and B. Engelhardt. 2003. Localization of claudin-3 in tight junctions of the blood-brain barrier is selectively lost during experimental autoimmune encephalomyelitis and human glioblastoma multiforme. Acta Neuropathol. 105: 586-592.
28. Wakeland, E., L. Morel, K. Achey, M. Yui, and J. Longmate. 1997. Speed congenics: a classic technique in the fast lane (relatively speaking). Immunol. Today 18: 472-477.
29. Amor, S., N. Groome, C. Linington, M. M. Morris, K. Dornmair, M. V. Gardinier, J. M. Matthieu, and D. Baker. 1994. Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB/H mice. J. Immunol. 153: 4349-4356.
30. Laird, P. W., A. Zijderveld, K. Linders, M. A. Rudnicki, R. Jaenisch, and A. Berns. 1991. Simplified mammalian DNA isolation procedure. Nucleic Acids Res. 19: 4293.
31. Jacob, H. J., D. M. Brown, R. K. Bunker, M. J. Daly, V. J. Dzau, A. Goodman, G. Koike, V. Kren, T. Kurtz, A. Lernmark, et al. 1995. A genetic linkage map of the laboratory rat, Rattus norvegicus. Nat. Genet. 9: 63-69.
32. Lander, E. S., P. Green, J. Abrahamson, A. Barlow, M. J. Daly, S. E. Lincoln, and L. Newburg. 1987. MAPMAKER: an interactive computer package for constructing primary genetic linkage maps of experimental and natural populations. Genomics 1: 174-181.
33. Broman, K. W., H. Wu, S. Sen, and G. A. Churchill. 2003. R/qt1: QTL mapping in experimental crosses. Bioinformatics 19: 889-890.
34. Doerge, R. W., and G. A. Churchill. 1996. Permutation tests for multiple loci affecting a quantitative character. Genetics 142: 285-294.
35. Churchill, G. A., and R. W. Doerge. 1994. Empirical threshold values for quantitative trait mapping. Genetics 138: 963-971.
36. Gracie, J. A., and J. A. Bradley. 1996. Interleukin-12 induces interferon-γ-dependent switching of IgG alloantibody subclass. Eur. J. Immunol. 26: 1217-1221.
37. Mussener, A., J. C. Lorentzen, S. Kleinau, and L. Klareskog. 1997. Altered Th1/Th2 balance associated with non-major histocompatibility complex genes in collagen-induced arthritis in resistant and non-resistant rat strains. Eur. J. Immunol. 27: 695-699.
38. Hultqvist, M., P. Olofsson, J. Holmberg, B. T. Backstrom, J. Tordsson, and R. Holmdahl. 2004. Enhanced autoimmunity, arthritis, and encephalomyelitis in mice with a reduced oxidative burst due to a mutation in the Ncf1 gene. Proc. Natl. Acad. Sci. USA 101: 12646-12651.
39. Lander, E. S., and D. Botstein. 1989. Mapping Mendelian factors underlying quantitative traits using RFLP linkage maps. Genetics 121: 185-199.
40. Olofsson, P., and R. Holmdahl. 2003. Positional cloning of Ncf1: a piece in the puzzle of arthritis genetics. Scand. J. Immunol. 58: 155-164.
41. Wolburg, H., K. Wolburg-Buchholz, S. Liebner, and B. Engelhardt. 2001. Clauduv-1, claudin-2 and claudin-11 are present in tight junctions of choroid plexus epithelium of the mouse. Neurosci. Lett. 307: 77-80.
42. Virgintino, D., M. Errede, D. Robertson, C. Capobianco, F. Girolamo, A. Vimercati, M. Bertossi, and L. Roncali. 2004. Immunolocalization of tight junction proteins in the adult and developing human brain. Histochem. Cell Biol. 122: 51-59.
43. Wilcox, E. R., Q. L. Burton, S. Naz, S. Riazuddin, T. N. Smith, B. Ploplis, I. Belyantseva, T. Ben-Yosef, N. A. Liburd, R. J. Morell, et al. 2001. Mutations in the gene encoding tight junction claudin-14 cause autosomal recessive deafness DFNB29. Cell 104: 165-172.
44. Eltayeb, S., D. Sunnemark, A. L. Berg, G. Nordvall, A. Malmberg, H. Lassmann, B. Wallstrom, T. Olsson, and A. Ericsson-Dahlstrand. 2003. Effector stage CC chemokine receptor-1 selective antagonism reduces multiple sclerosis-like rat disease. J. Neuroimmunol. 142: 75-85.
45. Smith, K. J., and H. Lassmann. 2002. The role of nitric oxide in multiple sclerosis. Lancet Neurol. 1: 232-241.
46. Smith, K. J., R. Kapoor, and P. A. Felts. 1999. Demyelination: the role of reactive oxygen and nitrogen species. Brain Pathol. 9: 69-92.
47. Redford, E. J., R. Kapoor, and K. J. Smith. 1997. Nitric oxide donors reversibly block axonal conduction: demyelinated axons are especially susceptible. Brain 120: 2149-2157.
48. Smith, K. J., and S. M. Hall. 2001. Factors directly affecting impulse transmission in inflammatory demyelinating disease: recent advances in our understanding. Curr. Opin. Neurol. 14: 289-298.
49. Cowden, W. B., F. A. Cullen, M. A. Staykova, and D. O. Willenborg. 1998. Nitric oxide is a potential down-regulating molecule in autoimmune disease: inhibition of nitric oxide production renders PVG rats highly susceptible to EAE. J. Neuroimmunol. 88: 1-8.
50. Torreilles, F., S. Salman-Tabcheh, M. Guerin, and J. Torreilles. 1999. Neurodegenerative disorders: the role of peroxynitrite. Brain Res. Brain Res. Rev. 30: 153-163.
51. Cross, A. H., M. San, M. K. Stern, R. M. Keeling, D. Salvemini, and T. P. Misko. 2000. A catalyst of peroxynitrite decomposition inhibits murine experimental autoimmune encephalomyelitis. J. Neuroimmunol 107: 21-28.
52. Danilov, A. I., M. Jagodic, N. P. Wiklund, T. Olsson, and L. Brundin. 2005. Effects of long term NOS inhibition on disease and the immune system in MOG-induced EAE. Nitric Oxide 13: 188-195.
53. Jagodic, M., K. Becanovic, J. R. Sheng, X. Wu, L. Backdahl, J. C. Lorentzen, E. Wallstrom, and T. Olsson. 2004. An advanced intercross line resolves Eae18 into two narrow quantitative trait loci syntenic to multiple sclerosis candidate loci. J. Immunol. 173: 1366-1373.
54. Monta, K., M. Furuse, K. Fujimoto, and S. Tsukita. 1999. Claudin multigene family encoding four-transmembrane domain protein components of tight junction strands. Proc. Natl. Acad. Sci. USA 96: 511-516.
55. Engelhardt, B. 2003. Development of the blood-brain barrier. Cell Tissue Res. 314: 119-129.